Ulrike M Litzenburger Selected Research

Ulrike M Litzenburger Research Topics

9	Neoplasms (Cancer) 01/2021 - 01/2011
3	Carcinogenesis 12/2022 - 10/2011
2	Hypoxia (Hypoxemia) 01/2020 - 11/2018
2	Glioma (Gliomas) 01/2015 - 01/2012
2	Glioblastoma (Glioblastoma Multiforme) 01/2015 - 01/2012
1	Breast Neoplasms (Breast Cancer) 12/2022
1	Neoplasm Metastasis (Metastasis) 12/2022
1	Neuroblastoma 01/2020
1	Neuroinflammatory Diseases 09/2013
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 09/2013
1	Herpes Zoster 09/2013
1	Inflammation (Inflammations) 10/2011

3	ChromatinIBA 12/2022 - 01/2017
3	Tryptophan (L-Tryptophan)FDA Link 01/2015 - 01/2011
2	Histones (Histone)IBA 01/2020 - 01/2012
2	EnzymesIBA 01/2015 - 10/2011
2	KynurenineIBA 10/2011 - 01/2011
1	Doxycycline (Periostat)FDA LinkGeneric 12/2022
1	Long Noncoding RNAIBA 12/2022
1	Pyruvic Acid (Pyruvate)IBA 01/2020
1	Acetates (Acetic Acid Esters)FDA Link 01/2020
1	Acetyl Coenzyme A (Acetyl-CoA)IBA 01/2020
1	Differentiation AntigensIBA 01/2020
1	CarbonIBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	Glycerol (Glycerine)FDA LinkGeneric 01/2020
1	alpha-hydroxyglutarateIBA 01/2020
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2020
1	Proteins (Proteins, Gene)FDA Link 11/2018
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2015
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2015
1	SteroidsIBA 01/2015
1	Transcription Factors (Transcription Factor)IBA 01/2015
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2015
1	Small Interfering RNA (siRNA)IBA 01/2015
1	tacrolimus binding protein 4 (FKBP52)IBA 01/2015
1	GlucocorticoidsIBA 01/2015
1	Interleukin-6 (Interleukin 6)IBA 02/2014
1	Claudin-5IBA 09/2013
1	Claudin-3IBA 09/2013
1	Protein Kinases (Protein Kinase)IBA 09/2013
1	bisindolylmaleimideIBA 09/2013
1	Phosphotransferases (Kinase)IBA 01/2012
1	Enhancer of Zeste Homolog 2 ProteinIBA 01/2012
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 10/2011
1	Polychlorinated Dibenzodioxins (TCDD)IBA 10/2011
1	XenobioticsIBA 10/2011
1	DioxinsIBA 10/2011
1	LigandsIBA 10/2011

2	Therapeutics 01/2021 - 01/2020
1	Immunotherapy 01/2021